Critically Ill Patients Clinical Trial
Official title:
Impact of Admission SOFA Score and 48-hour Delta SOFA on Clinical Outcomes in Critically Ill Patients
NCT number | NCT04980274 |
Other study ID # | 51 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2020 |
Est. completion date | December 31, 2020 |
Verified date | July 2021 |
Source | Hospital Sao Domingos |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Organ dysfunctions are associated with high morbidity and mortality. The SOFA (Sequential Organ Failure Assessment) score developed by Vincent et al. sequentially assesses the presence and severity of dysfunctions in six organ systems: respiratory, cardiovascular, coagulation, hepatic, neurological and renal. Although the SOFA score was created to quantify organ dysfunctions, the obvious relationship between organ dysfunctions and mortality has been widely documented. Dynamic measurements of the SOFA score assess response to treatment and can be used to search for perpetuating sources of severity and reassess the treatment plan. The primary objective of this study will be to assess the impact of an admission SOFA score equal to or greater than 2 and subsequent interventions on outcomes related to the 48-hour delta SOFA on ICU and hospital mortality, length of stay in the ICU, duration of mechanical ventilation, time of vasoactive drug use. Patients will be divided into three groups: those who did not trigger the SOFA trigger on admission to the ICU (Group 1), those who triggered the SOFA trigger and improved on the third day (Group 2) and, finally, those who triggered the SOFA trigger and worsened on the third day (Group 3).
Status | Completed |
Enrollment | 1410 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Included all patients over 18 years old admitted to the ICU during the study period Exclusion Criteria: - Excluded were patients who remained in the ICU for a period of less than 48 hours and pregnant women |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital Sao Domingos | São Luis | Maranhao |
Lead Sponsor | Collaborator |
---|---|
Hospital Sao Domingos |
Brazil,
de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs ? Sequential Organ Failure Assessment. J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.018. Epub 2014 Sep 10. — View Citation
Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8. — View Citation
Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009 May;37(5):1649-54. doi: — View Citation
Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. W — View Citation
Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, Pilcher DV; Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Sc — View Citation
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Proble — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement in SOFA score after 48 hours of ICU stay | Interventions designed to reverse or improve the organ dysfunction that motivated a SOFA score equal to or > 2 | 48 hours | |
Secondary | 28 day mortality | Interventions designed to reverse or improve the organ dysfunction that motivated a SOFA | 28 days | |
Secondary | Length of time without mechanical ventilation | Interventions designed to reverse or improve the organ dysfunction that motivated a SOFA | 28 days | |
Secondary | Length of time without vasopressor | Interventions designed to reverse or improve the organ dysfunction that motivated a SOFA | 28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04045366 -
Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
|
||
Completed |
NCT01411553 -
ECG Leadwires: Disposable Versus Cleaned, Reusable
|
N/A | |
Completed |
NCT00288743 -
Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
|
Phase 2 | |
Recruiting |
NCT03529617 -
Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
|
||
Not yet recruiting |
NCT05564975 -
Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
|
||
Recruiting |
NCT06234787 -
Continuous Subcutaneous Glucose Monitoring in Critical Patients
|
||
Completed |
NCT02198950 -
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
|
||
Recruiting |
NCT01317381 -
ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
|
Phase 4 | |
Completed |
NCT00470821 -
Oral Melatonin in Critically Ill High-risk Patients
|
Phase 4 | |
Completed |
NCT00460252 -
Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients.
|
N/A | |
Recruiting |
NCT06049979 -
Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients
|
||
Active, not recruiting |
NCT04793568 -
Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study
|
Phase 2 | |
Recruiting |
NCT05458687 -
Traditional Chinese Medicine for Complications in Critically Ill Patients
|
N/A | |
Completed |
NCT01963013 -
Non-returning Catheter Valve for Reducing CAUTI
|
N/A | |
Completed |
NCT01794468 -
A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study
|
N/A | |
Completed |
NCT03469882 -
High Protein Intake and Early Exercise in Adult Intensive Care Patients
|
N/A | |
Recruiting |
NCT04962204 -
Virtual Visitation in Intensive Care Unit Study
|
N/A | |
Completed |
NCT03205592 -
Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients
|
||
Recruiting |
NCT01995565 -
Regional Cerebral Hemodynamics Related to Global Hemodynamics
|
N/A | |
Completed |
NCT00143494 -
The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure
|
N/A |